14 October 2020 Coronavirus Charts and News: Of The Three COVID-19 Trials Paused To Date, Eli Lilly's Antibody Drug Pause Is Most Concerning As The Patients Were Already Hospitalized

Written by Steven Hansen

The U.S. new cases 7-day rolling average is 18.1 % HIGHER than the 7-day rolling average one week ago. U.S. deaths due to coronavirus are now 1.7 % HIGHER than the rolling average one week ago. At the end of this post is a set of interactive graphs and tables for the world and individual States – as well as today’s headlines which include;

• Early lockdowns prevented additional COVID-19 deaths in multiple countries
• NIH Starts Clinical Trial Testing Antibody Drugs in COVID-19 Patients
• Europe Reports Record-High 700,000 COVID-19 Cases Last Week
• Dutch woman dies after catching Covid-19 twice, the first reported reinfection death
• Lopinavir-Ritonavir Does Not Improve COVID-19 Outcomes
• New reports show coronavirus immunity can last for months
• FDA faults quality control at Lilly plant making Trump-touted COVID drug
• “Most transmission is actually still happening in households” WHO says
• Cases emerge of rare hearing loss after Covid-19

​​

Read more …